Philip Bonomi to Receptors, TNF-Related Apoptosis-Inducing Ligand
This is a "connection" page, showing publications Philip Bonomi has written about Receptors, TNF-Related Apoptosis-Inducing Ligand.
Connection Strength
0.019
-
Phase 2 study of mapatumumab, a fully human agonistic monoclonal antibody which targets and activates the TRAIL receptor-1, in patients with advanced non-small cell lung cancer. Lung Cancer. 2008 Jul; 61(1):82-90.
Score: 0.019